Machine learning-derived clinical decision algorithm for the diagnosis of hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism.

Hyperparathyroidism Machine learning Parathyroid Parathyroid 4D-CT Sestamibi SPECT

Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
30 Oct 2024
Historique:
received: 06 05 2024
accepted: 11 09 2024
revised: 23 07 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: aheadofprint

Résumé

To train and validate machine learning-derived clinical decision algorithm ( This retrospective study included 458 consecutive primary hyperparathyroidism (PHPT) patients who underwent combined 4D-CT and sestamibi SPECT/CT (MIBI) with subsequent parathyroidectomy from February 2013 to September 2016. The study cohort was divided into training (first 400 patients) and validation sets (remaining 58 patients). Sixteen clinical, laboratory, and imaging variables were evaluated. A random forest algorithm selected the best predictor variables and generated a clinical decision algorithm with the highest performance ( Of 16 variables, the algorithm selected 3 variables for optimal prediction: combined 4D-CT and MIBI using (1) sensitive reading, (2) specific reading, and (3) cross-product of serum calcium and parathyroid hormone levels and outputted an Machine learning generated a clinical decision algorithm that accurately diagnosed hyperfunctioning parathyroid glands through classification into probability categories, which can be implemented for improved preoperative planning and convey diagnostic certainty. Question Can an

Identifiants

pubmed: 39476058
doi: 10.1007/s00330-024-11159-8
pii: 10.1007/s00330-024-11159-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to European Society of Radiology.

Références

Rodgers SE, Hunter GJ, Hamberg LM et al (2006) Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 140:932–940
doi: 10.1016/j.surg.2006.07.028 pubmed: 17188140
Hoang JK, Sung WK, Bahl M, Phillips CD (2014) How to perform parathyroid 4D CT: tips and traps for technique and interpretation. Radiology 270:15–24
doi: 10.1148/radiol.13122661 pubmed: 24354373
Greene AB, Butler RS, McIntyre S et al (2009) National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 209:332–343
doi: 10.1016/j.jamcollsurg.2009.05.029 pubmed: 19717037
Kelly HR, Hamberg LM, Hunter GJ (2014) 4D-CT for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism: accuracy and ability to stratify patients by unilateral versus bilateral disease in surgery-naive and re-exploration patients. AJNR Am J Neuroradiol 35:176–181
doi: 10.3174/ajnr.A3615 pubmed: 23868155 pmcid: 7966477
Day KM, Elsayed M, Beland MD, Monchik JM (2015) The utility of 4-dimensional computed tomography for preoperative localization of primary hyperparathyroidism in patients not localized by sestamibi or ultrasonography. Surgery 157:534–539
doi: 10.1016/j.surg.2014.11.010 pubmed: 25660183
Eichhorn-Wharry LI, Carlin AM, Talpos GB (2011) Mild hypercalcemia: an indication to select 4-dimensional computed tomography scan for preoperative localization of parathyroid adenomas. Am J Surg 201:334–338
doi: 10.1016/j.amjsurg.2010.08.033 pubmed: 21367374
Kukar M, Platz TA, Schaffner TJ et al (2015) The use of modified four-dimensional computed tomography in patients with primary hyperparathyroidism: an argument for the abandonment of routine sestamibi single-positron emission computed tomography (SPECT). Ann Surg Oncol 22:139–145
doi: 10.1245/s10434-014-3940-y pubmed: 25074663
Starker LF, Mahajan A, Bjorklund P, Sze G, Udelsman R, Carling T (2011) 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol 18:1723–1728
doi: 10.1245/s10434-010-1507-0 pubmed: 21184187
Yeh R, Tay YD, Tabacco G et al (2019) Diagnostic performance of 4D CT and sestamibi SPECT/CT in localizing parathyroid adenomas in primary hyperparathyroidism. Radiology 291:469–476
doi: 10.1148/radiol.2019182122 pubmed: 30835187
Bilezikian JP (2018) Primary hyperparathyroidism. J Clin Endocrinol Metab 103:3993–4004
doi: 10.1210/jc.2018-01225 pubmed: 30060226 pmcid: 6182311
Lim JY, Herman MC, Bubis L et al (2017) Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism. Surgery 161:70–77
doi: 10.1016/j.surg.2016.08.054 pubmed: 27847113
Mazeh H, Chen H, Leverson G, Sippel RS (2013) Creation of a “Wisconsin index” nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy. Ann Surg 257:138–141
doi: 10.1097/SLA.0b013e31825ffbe1 pubmed: 22801087
Sepahdari AR, Bahl M, Harari A, Kim HJ, Yeh MW, Hoang JK (2015) Predictors of multigland disease in primary hyperparathyroidism: a scoring system with 4D-CT imaging and biochemical markers. AJNR Am J Neuroradiol 36:987–992
doi: 10.3174/ajnr.A4213 pubmed: 25556203 pmcid: 7990586
Sho S, Yilma M, Yeh MW et al (2016) Prospective validation of two 4D-CT-based scoring systems for prediction of multigland disease in primary hyperparathyroidism. AJNR Am J Neuroradiol 37:2323–2327
doi: 10.3174/ajnr.A4948 pubmed: 27659191 pmcid: 7963886
Choy G, Khalilzadeh O, Michalski M et al (2018) Current applications and future impact of machine learning in radiology. Radiology 288:318–328
doi: 10.1148/radiol.2018171820 pubmed: 29944078
Kohli M, Prevedello LM, Filice RW, Geis JR (2017) Implementing machine learning in radiology practice and research. AJR Am J Roentgenol 208:754–760
doi: 10.2214/AJR.16.17224 pubmed: 28125274
Bahl M, Sepahdari AR, Sosa JA, Hoang JK (2015) Parathyroid adenomas and hyperplasia on four-dimensional CT scans: three patterns of enhancement relative to the thyroid gland justify a three-phase protocol. Radiology 277:454–462
doi: 10.1148/radiol.2015142393 pubmed: 26024308
Yeh R, Tay YD, Dercle L, Bandeira L, Parekh MR, Bilezikian JP (2020) A simple formula to estimate parathyroid weight on 4D-CT, predict pathologic weight, and diagnose parathyroid adenoma in patients with primary hyperparathyroidism. AJNR Am J Neuroradiol 41:1690–1697
pubmed: 32816774 pmcid: 7583096
Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL 3rd (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: Which criterion is the most accurate? Surgery 134:973–979
doi: 10.1016/j.surg.2003.06.001 pubmed: 14668730
Panicek DM, Hricak H (2016) How sure are you, doctor? A standardized lexicon to describe the radiologist’s level of certainty. AJR Am J Roentgenol 207:2–3
doi: 10.2214/AJR.15.15895 pubmed: 27065212
Schwartz LH, Panicek DM, Berk AR, Li Y, Hricak H (2011) Improving communication of diagnostic radiology findings through structured reporting. Radiology 260:174–181
doi: 10.1148/radiol.11101913 pubmed: 21518775 pmcid: 3121011
Edafe O, Collins EE, Ubhi CS, Balasubramanian SP (2018) Current predictive models do not accurately differentiate between single and multi gland disease in primary hyperparathyroidism: a retrospective cohort study of two endocrine surgery units. Ann R Coll Surg Engl 100:140–145
doi: 10.1308/rcsann.2017.0112 pubmed: 29022783
Imbus JR, Randle RW, Pitt SC, Sippel RS, Schneider DF (2017) Machine learning to identify multigland disease in primary hyperparathyroidism. J Surg Res 219:173–179
doi: 10.1016/j.jss.2017.05.117 pubmed: 29078878 pmcid: 5661967
Somnay YR, Craven M, McCoy KL et al (2017) Improving diagnostic recognition of primary hyperparathyroidism with machine learning. Surgery 161:1113–1121
doi: 10.1016/j.surg.2016.09.044 pubmed: 27989606

Auteurs

Randy Yeh (R)

Department of Radiology, New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA. yehr@mskcc.org.
Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. yehr@mskcc.org.

Jennifer H Kuo (JH)

Division of GI/Endocrine Surgery, Department of Surgery, College of Physicians & Surgeons, Columbia University, New York, NY, USA.

Bernice Huang (B)

Division of GI/Endocrine Surgery, Department of Surgery, College of Physicians & Surgeons, Columbia University, New York, NY, USA.

Parnian Shobeiri (P)

Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

James A Lee (JA)

Division of GI/Endocrine Surgery, Department of Surgery, College of Physicians & Surgeons, Columbia University, New York, NY, USA.

Yu-Kwang Donovan Tay (YD)

Division of Endocrinology, Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY, USA.
Department of Medicine, Sengkang General Hospital, Singhealth Singapore, Singapore, Singapore.

Gaia Tabacco (G)

Division of Endocrinology, Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY, USA.
Unit of Endocrinology and Diabetes, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.

John P Bilezikian (JP)

Division of Endocrinology, Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY, USA.

Laurent Dercle (L)

Department of Radiology, New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA.

Classifications MeSH